Source-grounded facts extracted from THERMO FISHER SCIENTIFIC INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
THERMO FISHER SCIENTIFIC INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-05-20 meeting.
“3. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified. For Against Abstain 296,866,709 36,064,900 999,237”
THERMO FISHER SCIENTIFIC INC. shareholders rejected A non-binding, advisory proposal on the compensation of the Company’s named executive officers at the 2026-05-20 meeting.
“2. A non-binding, advisory proposal on the compensation of the Company’s named executive officers was not approved. For Against Abstain 99,928,178 214,525,673 1,265,524”
THERMO FISHER SCIENTIFIC INC. shareholders approved Election of Directors at the 2026-05-20 meeting.
“1. The following nominees were elected to the Company’s Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders. For Against Abstain Marc N. Casper 294,015,478 20,501,640 1,202,257 Nelson J. Chai 293,142,241 21,615,744 961,390 Ruby R. Chandy 312,259,374 2,490,403 969,598 C. Martin Harris 285,543,740 28,753,064 1,422,571 Tyler Jacks 304,372,357 10,373,697 973,321 Jennifer M. Johnson 304,583,443 10,151,215 984,717 R. Alexandra Keith 308,290,311 6,269,824 1,159,240 Karen S. Lynch 308,933,071 5,811,374 974,930 Debora L. Spar 314,426,121 311,821 981,433 Scott M. Sperling 292,218,754 22,524,675 975,946 Dion J. Weisler 281,791,656 32,960,105 967,614”
THERMO FISHER SCIENTIFIC INC. reported first quarter ended March 28, 2026 results: revenue $11.01 billion, net income $1.86 billion, EPS $4.43.
“the world leader in serving science, today reported its financial results for the first quarter ended March 28, 2026. First Quarter Highlights • First quarter revenue grew 6% to $11.01 billion. • First quarter GAAP diluted earnings per share (EPS) grew 11% to $4.43. • First quarter adjusted EPS grew 6% to $5.44. • Delivered excellent performance in the first quarter,”
THERMO FISHER SCIENTIFIC INC. entered into Indenture (Base Indenture dated November 20, 2009 and Thirtieth Supplemental Indenture dated February 12, 2026) with The Bank of New York Mellon Trust Company, N.A. valued at $3.8 billion aggregate principal amount of senior notes with interest rates from 4.215% to 5.546% an (effective 2026-02-12).
“On February 12, 2026, Thermo Fisher Scientific Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of 4.215% Senior Notes due 2031 (the “2031 Notes”), $750,000,000 aggregate principal amount of 4.550% Senior Notes due 2033 (the “2033 Notes”), $1,300,000,000 aggregate principal amount of 4.902% Senior Notes due 2036 (the “2036 Notes”) and $750,000,000 aggregate principal amount of 5.546% Senior Notes due 2046 (the “2046 Notes” and, collectively with the 2031 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in a public offering (the “Offering”) pursuant to a registration statement on Form S-3ASR (File No. 333- 285159) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the Securities and Exchange Commission. The Notes were issued under an indenture, dated as of November 20, 2009 (the “Base Indenture”) and the Thirtieth Supplemental Indenture, dated as of February 12, 2026 (the “Suppl”
THERMO FISHER SCIENTIFIC INC. entered into Fifth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at €1,000,000,000 aggregate principal amount of Floating Rate Senior Notes due 2027 and €1,100,000,000 (effective 2025-12-01).
“On December 1, 2025, Thermo Fisher Scientific (Finance I) B.V. (“Thermo Fisher International”), an indirect, wholly-owned finance subsidiary of Thermo Fisher Scientific Inc. (the “Company”), issued €1,000,000,000 aggregate principal amount of Floating Rate Senior Notes due 2027 (the “Floating Rate Notes”) and €1,100,000,000 aggregate principal amount of 3.628% Senior Notes due 2035 (the “Fixed Rate Notes” and, together with the Floating Rate Notes, the “Notes”) in a public offering (the “Offering”) pursuant to a registration statement on Form S-3ASR (File No. 333-285159) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the Securities and Exchange Commission. The Company has fully and unconditionally guaranteed the Notes on a senior unsecured basis (the “Guarantees” and, together with the Notes, the “Securities”). The Securities were issued under an indenture, dated as of August 9, 2016 (the “Base Inden”
Karen S. Lynch was elected as director at THERMO FISHER SCIENTIFIC INC..
“increased its size to twelve members and elected Karen S. Lynch as a director of the Company, effective February 19, 2025, for a term expiring at the Company’s 2025 annual meeting.”
THERMO FISHER SCIENTIFIC INC. reported financial results for the fiscal quarter ended March 30, 2024.
“On April 24, 2024, the Registrant announced its financial results for the fiscal quarter ended March 30, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.”
THERMO FISHER SCIENTIFIC INC. updated its the fiscal quarter and year ended December 31, 2023 guidance (initiated).
“On January 31, 2024, the Registrant announced its financial results for the fiscal quarter and year ended December 31, 2023.”
THERMO FISHER SCIENTIFIC INC. entered into Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2023-12-05).
“The Notes were issued under an indenture, dated as of November 20, 2009 (the “Base Indenture”), and the Twenty-Eighth Supplemental Indenture, dated as of December 5, 2023 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee.”
THERMO FISHER SCIENTIFIC INC. entered into Twenty-Eighth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at $1,000,000,000 aggregate principal amount of 5.000% Senior Notes due 2026, $1,000,000,000 aggregate (effective 2023-12-05).
“On December 5, 2023, Thermo Fisher Scientific Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of 5.000% Senior Notes due 2026 (the “2026 Notes”), $1,000,000,000 aggregate principal amount of 5.000% Senior Notes due 2029 (the “2029 Notes”) and $500,000,000 aggregate principal amount of 5.200% Senior Notes due 2034 (the “2034 Notes” and, collectively with the 2026 Notes and the 2029 Notes, the “Notes”) in a public offering (the “Offering”) pursuant to a registration statement on Form S-3 (File No. 333-263034) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the Securities and Exchange Commission.”
THERMO FISHER SCIENTIFIC INC. reported the fiscal quarter ended September 30, 2023 results: revenue $10.57 billion, EPS $4.42. Guidance lowered.
“world leader in serving science, today reported its financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights • Third quarter revenue was $10.57 billion, 1% lower versus the same quarter last year. Core organic revenue growth was 1%. • Third quarter GAAP diluted earnings per share (EPS) was $4.42, 17% higher versus the same”
THERMO FISHER SCIENTIFIC INC. entered into Twenty-Seventh Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at $2,950,000,000 aggregate principal amount (effective 2023-08-10).
“On August 10, 2023, Thermo Fisher Scientific Inc. (the “Company”) issued $600,000,000 aggregate principal amount of 4.953% Senior Notes due 2026 (the “2026 Notes”), $750,000,000 aggregate principal amount of 4.977% Senior Notes due 2030 (the “2030 Notes”), $1,000,000,000 aggregate principal amount of 5.086% Senior Notes due 2033 (the “2033 Notes”) and $600,000,000 aggregate principal amount of 5.404% Senior Notes due 2043 (the “2043 Notes” and, together with the 2026 Notes, the 2030 Notes and the 2033 Notes, the “Notes”) in a public offering (the “Offering”) pursuant to a registration statement on Form S-3 (File No. 333-263034) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the Securities and Exchange Commission.”
THERMO FISHER SCIENTIFIC INC. reported the fiscal quarter ended July 1, 2023 results: revenue $10.69 billion, EPS $3.51. Guidance lowered.
“the world leader in serving science, today reported its financial results for the second quarter ended July 1, 2023. Second Quarter 2023 Highlights • Second quarter revenue was $10.69 billion, 3% lower versus the same quarter last year. Core organic revenue growth was 2%. • Second quarter GAAP diluted earnings per share (EPS) was $3.51. • Second quarter adjusted EPS”
Jennifer Johnson was elected as director at THERMO FISHER SCIENTIFIC INC..
“elected Jennifer “Jenny” Johnson, president and chief executive officer of Franklin Resources, Inc., as a director of the Company, effective July 13, 2023”
THERMO FISHER SCIENTIFIC INC. shareholders approved 2023 Global Employee Stock Purchase Plan at the 2023-05-24 meeting.
“The 2023 Global Employee Stock Purchase Plan was approved.”
THERMO FISHER SCIENTIFIC INC. shareholders approved Amended and Restated 2013 Stock Incentive Plan at the 2023-05-24 meeting.
“The Amended and Restated 2013 Stock Incentive Plan was approved.”
THERMO FISHER SCIENTIFIC INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-05-24 meeting.
“The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023 was ratified.”
THERMO FISHER SCIENTIFIC INC. shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2023-05-24 meeting.
“Shareholders approved, on an advisory basis, a frequency of “1 Year” for future advisory votes on named executive officer compensation.”
THERMO FISHER SCIENTIFIC INC. shareholders approved Non-binding advisory proposal on compensation of named executive officers at the 2023-05-24 meeting.
“A non-binding, advisory proposal on the compensation of the Company’s named executive officers was approved.”
THERMO FISHER SCIENTIFIC INC. shareholders approved Election of Directors at the 2023-05-24 meeting.
“The following nominees were elected to the Company’s Board of Directors for a one-year term expiring at the 2024 annual meeting of shareholders.”
THERMO FISHER SCIENTIFIC INC. reported first quarter ended April 1, 2023 results: revenue $10.71 billion, EPS $5.03.
“results for the first quarter ended April 1, 2023. First Quarter 2023 Highlights • Delivered very strong financial results during the first quarter. • First quarter revenue was $10.71 billion, 9% lower versus the same quarter last year. Core organic revenue growth was 6%. • First quarter GAAP diluted earnings per share (EPS) was $3.32. • First quarter adjusted EPS was”
THERMO FISHER SCIENTIFIC INC. reported Full Year 2023 results: revenue $45.3 billion, EPS $23.7. Guidance initiated.
“The company expects to achieve 2023 revenue of $45.3 billion and full year Core organic revenue growth of 7%. The company expects to achieve adjusted EPS of $23.7”
THERMO FISHER SCIENTIFIC INC. entered into Twenty-Sixth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at $600,000,000 and $600,000,000 (effective 2022-11-21).
“USD Offering On November 21, 2022, the Company issued $600,000,000 aggregate principal amount of 4.800% Senior Notes due 2027 (the “2027 Notes”) and $600,000,000 aggregate principal amount of 4.950% Senior Notes due 2032 (the “2032 Notes” and, together with the 2027 Notes, the “USD Notes”) in a public offering (the “USD Offering”) pursuant to a registration statement on Form S-3 (File No. 333-263034) and a preliminary prospectus supplement and prospectus supplement related to the offering of the USD Notes, each as previously filed with the SEC. The USD Notes were issued under the Base Indenture and the Twenty-Sixth Supplemental Indenture, dated as of November 21, 2022 (the “USD Supplemental Indenture” and, together with the Base Indenture, the “USD Indenture”), between the Company and the Trustee.”
THERMO FISHER SCIENTIFIC INC. entered into Twenty-Fifth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at €500,000,000 and €750,000,000 (effective 2022-11-21).
“On November 21, 2022, Thermo Fisher Scientific Inc. (the “Company”) issued €500,000,000 aggregate principal amount of 3.200% Senior Notes due 2026 (the “2026 Notes”) and €750,000,000 aggregate principal amount of 3.650% Senior Notes due 2034 (the “2034 Notes”, and, together with the 2026 Notes, the “Euro Notes”) in a public offering (the “Euro Offering”) pursuant to a registration statement on Form S-3 (File No. 333-263034) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Euro Notes, each as previously filed with the Securities and Exchange Commission (the “SEC”). The Euro Notes were issued under an indenture, dated as of November 20, 2009 (the “Base Indenture”), and the Twenty-Fifth Supplemental Indenture, dated as of November 21, 2022 (the “Euro Supplemental Indenture” and, together with the Base Indenture, the “Euro Indenture”), between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Truste”
Thomas J. Lynch departed as director at THERMO FISHER SCIENTIFIC INC..
“Also on February 23, 2022, Thomas J. Lynch, who has served as a director of the Company since 2009, and as Lead Director since 2020, advised the Board that he plans to retire from the Board when his current term as a director expires at the 2022 annual meeting.”
Ruby R. Chandy was elected as director at THERMO FISHER SCIENTIFIC INC..
“On February 23, 2022, the Board of Directors of Thermo Fisher Scientific Inc. (the “Company”) increased the size of its board to thirteen members and elected Ruby R. Chandy as a director of the Company for a term expiring at the Company’s 2022 annual meeting, both effective as of March 1, 2022.”
Gianluca Pettiti was appointed as Executive Vice President at THERMO FISHER SCIENTIFIC INC..
“the Board of Directors of the Company appointed Gianluca Pettiti, currently Senior Vice President and President of the Company’s Specialty Diagnostics business, Executive Vice President, effective December 27, 2021.”
Michel Lagarde was appointed as Executive Vice President and Chief Operating Officer at THERMO FISHER SCIENTIFIC INC..
“the Board of Directors of the Company appointed Michel Lagarde, currently Executive Vice President, Executive Vice President and Chief Operating Officer, effective January 1, 2022.”
Syed Jafry retired as Senior Vice President, Regions at THERMO FISHER SCIENTIFIC INC..
“Syed Jafry, Senior Vice President, Regions, notified the Company of his decision to retire effective March 31, 2022.”
Mark Stevenson retired as Executive Vice President and Chief Operating Officer at THERMO FISHER SCIENTIFIC INC..
“Mark Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific Inc. (the “Company”), notified the Company of his decision to retire effective March 18, 2022”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.